Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.
Jiang SX, Walton RN, Hueniken K, Baek J, McCartney A, Labbé C, Smith E, Chan SWS, Chen R, Brown C, Patel D, Liang M, Eng L, Sacher A, Bradbury P, Leighl NB, Shepherd FA, Xu W, Liu G, Hurry M, O'Kane GM.
Jiang SX, et al.
Cancer Med. 2019 Dec;8(18):7542-7555. doi: 10.1002/cam4.2603. Epub 2019 Oct 24.
Cancer Med. 2019.
PMID: 31650705
Free PMC article.